SproutNews logo

Creatinine Test Market by Key Types – Blood Test, Urine Test and Creatinine Clearance Test with Top Players Till 2023

The Global Creatinine Test Market is anticipated to reach a valuation of USD 604.55 million by 2023, expanding at a 5.8% CAGR during the assessment period (2018-2023). Alarming cases of kidney disorders, namely chronic kidney disease (CKD) among patients.

Pune, India – July 13, 2018 /MarketersMedia/

Creatinine Test Market Overview

The Global Creatinine Test Market is anticipated to reach USD 604.5 million by 2023, as per a new report by Market Research Future (MRFR). It is expected to exhibit a phenomenal CAGR during the assessment period (2017-2023). The growth is supplemented by government initiatives and campaigns to create awareness among users to minimize the incidence of chronic kidney diseases. In addition, launch of diagnostic tests annually by current and new manufacturers is anticipated to spur market growth over the forecast period.

Creatinine tests are an array of tests used in checking on creatinine levels in kidneys. Creatinine is a waste product filtered through the kidneys and excreted via urine. Excess of creatinine in the blood can lead to kidney failure. Tests such as creatinine clearance and others to discern the glomerular filtration rate (GFR) are expected to diagnose chronic kidney disease at an early stage. Automation of laboratory tests and rise in research and development to expedite testing rates are expected to augur the creatinine test market over the forecast period.

Get Premium Sample Copy @ https://www.marketresearchfuture.com/sample_request/4878 .

Segment Overview

By test type, the creatinine test market has been segmented into urine test, creatinine clearance test, and blood test. By product type, the market is segmented into consumables and instruments. Based on application, the market has been segmented into glomerulonephritis, kidney cancer, renal failure, urinary tract obstruction, and others. End-users covered are research institutes, diagnostic centers, hospitals & clinics, and others. 

The segments and sub-segments covered in the report are analyzed under four major regions –Americas, Europe, Asia Pacific, and the Middle East and Africa, with respective country-level market sizing. For the scope of research, the standard definition of the product/ service “creatinine test” is included in the report. The report discusses and interprets the current and future opportunities of the industry delivering an unbiased growth assessment.

Top Players Covered

Quest Diagnostics, Thermo Fisher Scientific, Inc., Abbott, F. Hoffmann-La Roche AG, ARKRAY, Inc., ACON Laboratories, Inc., Abcam plc, URIT Medical, The Danaher Corporation, Siemens AG, Nova Biomedical, OPTI Medical Systems, and others are prominent players in the creatinine test market.

Global Creatinine Test Market: Competitive Landscape

Siemens AG, Abbott Diagnostics Inc., Thermo Fisher Scientific, F. Hoffmann-La Roche AG, and The Danaher Corporation collectively accounted for more than 70.5% market share of the global creatinine test market in 2016. These companies continue to retain their strong global presence through acquisitions and product launches.

In 2016, Siemens accounted for the largest market share of the global creatinine test market, with more than 21.2% of the market share. The large share of the company is attributed to the high demand for creatinine testing globally. Moreover, this company offers various new products in the creatinine test market. For instance, in 2018, Siemens Healthineers received an FDA approval for its Blood Urea Nitrogen (BUN) and Total Carbon Dioxide (TCO2) point-of-care tests to aid in the diagnosis of renal diseases and metabolic imbalances.

Abbott held the second position in terms of market share, in 2016. The company focuses on delivering integrated solutions to large healthcare customers. Also, the company is focusing on acquisitions for establishing a strong position in the market. For instance, in Oct 2017, Abbott completed the acquisition of Alere Inc. for USD 5.3 Billion. The acquisition will establish a strong position of Abbott in the diagnostics market.

Thermo Fisher Scientific Inc. acquired the third spot in the market. The company follows a strategy of introducing a strong product portfolio at lower costs which help them to retain the position in the market.

 Major TOC Creatinine Test Market:

1 Report Prologue

2 Executive Summary

3 Market Introduction

4 Research Methodology

5 Market Dynamics

6 Market Factor Analysis

7 Global Creatinine Test Market, by Test Type

8 Global Creatinine Test Market, by Product Type

9 Global Creatinine Test Market, By Application

10 Global Creatinine Test Market, by End User

11 Creatinine Test Market, by Region

12 Competitive Landscape

13 Company Profiles

14 Conclusion

15 Appendix

Any Questions to Expertise @ https://www.marketresearchfuture.com/enquiry/4878 .

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Info:
Name: Market Research Future
Email: sales@marketresearchfuture.com
Organization: Market Research Future
Address: Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune – 411028 Maharashtra, India
Phone: +1 646 845 9312

Source URL: https://marketersmedia.com/creatinine-test-market-by-key-types-blood-test-urine-test-and-creatinine-clearance-test-with-top-players-till-2023/377598

For more information, please visit https://www.marketresearchfuture.com/reports/creatinine-test-market-4878

Source: MarketersMedia

Release ID: 377598

Go Top